Partner

Articles & Insights / Low Dose Formulations

Low Dose Vitamin D Products Need Precise Units and Uniform Distribution

Vitamin D formulations combine a small active quantity with a much larger carrier system. Unit conversion, premix design, sampling and dispensing performance therefore have a direct effect on whether each intended portion contains the declared amount.

Stabicon Life Sciences3 min read

Accreditations, approvals & registrations

  • Prequalified by WHO, Geneva

    One of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

  • Accredited by ISO/IEC 17025:2017 (NABL)

  • Approved by FSSAI

  • Approved by CDSCO, India

  • Facility Registered with FDA, Karnataka

  • Registered with DSIR

  • Registered with AYUSH

All articles

What this article helps you consider

  • Start with the correct quantity and basis
  • Design the premix around distribution
  • Measure the unit the user receives

Start with the correct quantity and basis

Vitamin D may be expressed in micrograms or international units. For vitamin D, one microgram corresponds to 40 IU. Thus, 1,000 IU corresponds to 25 micrograms. These figures explain unit conversion and are not a recommended serving or dose. Permitted levels and intended populations must be established separately for the target market. R57R21

The illustration places this quantity in a hypothetical one-gram unit: 25 micrograms per gram is 25 parts per million by mass. The example shows why a small weighing, distribution or calculation error can be important. The ingredient supplied may be a premix with a specified potency rather than pure vitamin D, so its required mass must follow the actual certificate.

Explore the scienceLow Dose Formulations
Vitamin D activity1,000 IU
Vitamin D mass25 µg= 0.025 mg
In a hypothetical 1 g unit25 ppmBy mass

For vitamin D, 1 µg = 40 IU. This is a unit conversion, not a recommended serving or dose.

For vitamin D, 1,000 IU equals 25 micrograms or 0.025 mg. In a hypothetical one-gram unit, that mass is 25 ppm. This is a unit conversion, not a recommended dose.

Design the premix around distribution

Direct addition of a very small active quantity to a large blend can create uneven distribution. A suitable carrier or premix increases the practical amount handled, but its particle properties and mixing behaviour still need assessment. Geometric dilution is a useful technique in suitable circumstances, not a guarantee against later segregation.

Compare particle size, density, electrostatic behaviour and the process sequence. A blend that appears uniform immediately after mixing may segregate during transfer, hopper discharge or filling. Sampling should examine the stages and locations relevant to the final unit, with appropriate attention to sampling bias.

Measure the unit the user receives

A batch composite assay establishes average content under the sampling plan. It does not by itself demonstrate individual-unit distribution. Decide which uniformity measurements are appropriate to the dosage form, category and intended use, and ensure that the method is sensitive at the relevant low level.

For liquid drops, concentration per millilitre does not establish content per drop. The device, viscosity, temperature, dispensing angle and bottle use can affect delivered volume. Evaluate the supplied system and the proposed instructions rather than assume that a nominal drop volume is constant for every formulation.

Preserve the active through processing

Select the chemical form, carrier and protective approach using compatibility evidence. Light, oxygen, heat and interactions with other ingredients can contribute to degradation under relevant conditions. A protective premix may reduce some exposures but can be damaged by processing or dispersed differently from the main blend.

A hypothetical tablet may meet the mean assay after manufacture while a change in processing increases variability. Investigate both physical distribution and chemical recovery. A low result in a particular unit could have a different cause from a uniform decline across all units during storage.

Develop a method suited to the matrix

Extraction from oil, a compressed tablet or a chewable can require different preparation strategies. Establish recovery and specificity rather than assume that a method for a high-potency raw material works at the finished-product level. Protect preparations from demonstrated sources of instability and define their permitted holding time.

Use the appropriate standard value and unit basis in calculations. Errors between micrograms and milligrams or between premix mass and active content can produce large discrepancies. Validate spreadsheet formulas against independent calculations, including the reporting unit shown on the final certificate.

Confirm stability and packaging together

Track relevant chemical and physical attributes in the intended pack. For multidose liquids, add dispensing and in-use questions where appropriate. A justified overage must comply with applicable safety and regulatory constraints and should not substitute for correcting avoidable instability or poor uniformity.

Stabicon can integrate premix selection, formulation, low-level analysis and stability evaluation so that a vitamin D product is assessed at the quantity and format the user actually receives.

References & further reading

Read the source in its stated scope. Requirements, amendments and compendial editions depend on the product and target market. Draft guidance is identified separately.

  1. R57
    NIH Office of Dietary Supplements Vitamin D

    Health-professional fact sheet. Includes microgram and IU conversion; no dose advice is inferred here.

  2. R21
    FSSAI Health Supplements and Nutraceuticals Standards

    Official regulations portal. Verify current amendments, permitted ingredients, levels and category-specific requirements.

  3. R04
    ICH Q2 R2 Validation of Analytical Procedures

    Final guideline adopted November 2023. Analytical validation framework.

  4. R50
    USP General Chapter 11 Reference Standards

    Official publisher preview. Intended use and reference-material framework.

From insight to a defined programme

Bring your next technical question.

Share your formulation, testing objective or development challenge. Stabicon can review the context and define a suitable scope of work.

Discuss this topic with Stabicon

Continue reading

Related scientific perspectives.

Stabicon Life Sciences

Science-Led Formulations. Scalable Health Platforms.

Offices

Corporate Office

22, 7th Cross, Jaibharath Nagar, Bengaluru 560 033, Karnataka, India

Research & Development

28, Bommasandra Industrial Area, 4th Phase, Jigani Hobli, Anekal Taluk, Bengaluru 560 099, Karnataka, India

Newsletter

Quarterly briefings on platforms, science & partnerships.

No spam. Request a consent withdrawal at bd@stabicon.com.

Press Kit

Logos, company information & spokesperson details – available from our media team.

Request Press Kit

Accreditations

Prequalified by WHO, GenevaAccredited by ISO/IEC 17025:2017 (NABL)Approved by FSSAIApproved by CDSCO, IndiaFacility Registered with FDA, KarnatakaRegistered with DSIRRegistered with AYUSHOne of the Only 6 Commercial Testing Facilities in India to have a WHO Geneva Approval

Disclaimer: The information provided on this website is for educational and informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Product packaging and materials may vary from those shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.

© 2026 Stabicon Life Sciences Pvt. Ltd. All rights reserved.

Science-Led Formulations. Scalable Health Platforms.

Admin